sodium
Small moleculeexperimental
Clinical trial activity
4 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
1
Phase 4
1
Earliest trial started Jan 31, 2014 (NCT02135146)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 2 Sponsor(trial)
Indications
Approved for
Mechanism of action
- sodiumSupplementation
sodium supplementation
Chemistry & pharmacology
Loading structure…
SMILES
[Na]- Mol. weight
- 22.98976928 g/mol
Oral
No
Parenteral
No
Topical
No
Sources
- NCATS9NEZ333N27 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05283850 | Phase 2/Phase 3 (Phase 3) | Feb 16, 2022 | Virginia Polytechnic Institute and State University |
| NCT05515900 | N/A | Oct 1, 2021 | American Heart Association, Augusta University |
| NCT05649631 | N/A | Jul 1, 2021 | Jiao Tong University |
| NCT02135146 | Phase 4 | Jan 31, 2014 | University of Colorado, Denver |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| American Heart Association | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Augusta University | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Jiao Tong University | Academic/Hospital | 1 | 1 | 1 | 2021 |
| University of Colorado, Denver | Academic/Hospital | 1 | 1 | 1 | 2014 |
| Virginia Polytechnic Institute and State University | Academic/Hospital | 1 | 1 | 1 | 2022 |
5 organizations
Page 1 / 1